What is the lowest approved dose of lercanidipine (Zanidip) for treating hypertension in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lowest Dose of Zanidip (Lercanidipine)

The lowest approved dose of lercanidipine (Zanidip) for treating hypertension in adults is 10 mg once daily.

Dosing Information

The standard starting dose is 10 mg once daily, which can be increased to 20 mg once daily if blood pressure control is inadequate 1, 2, 3. While some research has evaluated lower doses (2.5 mg and 5 mg), these were found to be ineffective for sustained 24-hour blood pressure control 4.

Key Dosing Details:

  • Starting dose: 10 mg once daily
  • Maximum dose: 20 mg once daily
  • Timing: Can be taken at any time of day that is most convenient for the patient to establish a habitual pattern and improve adherence 5
  • No dose adjustment needed for elderly patients or those with moderate renal or hepatic impairment 1

Evidence Supporting 10 mg as Minimum Effective Dose

A well-designed ambulatory blood pressure monitoring study evaluated lercanidipine at 2.5, and 10 mg doses 4. The findings were clear:

  • 2.5 mg: No clinically relevant blood pressure reduction; effect was superimposable on placebo
  • 5 mg: Inconsistent effect that did not last 24 hours
  • 10 mg: Significant and durable antihypertensive effect over 24 hours with a smoothness index of 1.0±0.7 for systolic and 1.0±0.9 for diastolic blood pressure

The 10 mg dose achieved blood pressure reductions of 12±11/9±7 mmHg in clinic measurements and 9±7/7±5 mmHg on 24-hour ambulatory monitoring, both significantly superior to placebo 4.

Clinical Context

This aligns with current hypertension guidelines recommending starting with low-dose calcium channel blockers as part of initial therapy 6, 5. The 10 mg dose provides effective blood pressure lowering with excellent tolerability, particularly regarding peripheral edema compared to other dihydropyridine calcium channel blockers like amlodipine 7.

Do not attempt to use doses below 10 mg, as they lack demonstrated efficacy for sustained blood pressure control throughout the dosing interval.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.